How to manage hyperglycemia in a patient who received NPH insulin 24 units at 9 am and has a blood sugar level of 400 at 5 pm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Hyperglycemia with NPH Insulin

For a patient with a blood sugar of 400 mg/dL at 5 pm after receiving NPH insulin 24 units at 9 am, administer a rapid-acting insulin analog (such as insulin aspart or lispro) immediately as a correction dose based on the patient's blood glucose level, typically 6-8 units for a blood glucose >300 mg/dL. 1, 2

Understanding the Problem

This scenario represents a common challenge with NPH insulin:

  • NPH insulin has a peak action around 4-6 hours after administration and a duration of 10-16 hours
  • The 9 am administration means peak action occurred around 1-3 pm
  • By 5 pm, the insulin effect is waning while blood glucose remains severely elevated (400 mg/dL)
  • This pattern suggests either:
    • Insufficient NPH dosing
    • Inappropriate timing of NPH for the patient's needs
    • Missed meal bolus insulin
    • Excessive carbohydrate intake during the day

Immediate Management

  1. Administer correction dose of rapid-acting insulin:

    • For blood glucose >300 mg/dL: 8 units of rapid-acting insulin (aspart, lispro, or glulisine) 2, 3
    • Inject subcutaneously into abdomen, thigh, or upper arm
    • Monitor blood glucose in 2 hours to ensure improvement
  2. Hydration:

    • Encourage oral fluids if the patient is alert and not nauseated
    • Assess for signs of dehydration or diabetic ketoacidosis (DKA)

Adjusting the Insulin Regimen

After addressing the immediate hyperglycemia, modify the regimen to prevent recurrence:

  1. Adjust NPH insulin:

    • Consider splitting the NPH dose (⅔ in morning, ⅓ in evening) to provide better 24-hour coverage 1
    • Increase total daily NPH dose by 10-20% if fasting and pre-meal glucose levels are consistently elevated
  2. Add mealtime insulin:

    • Add rapid-acting insulin before meals to control postprandial glucose excursions
    • Starting dose: 0.1 units/kg or 4-6 units per meal 2
    • This combination provides better coverage than NPH alone
  3. Consider alternative insulin regimens:

    • NPH plus rapid-acting insulin at meals (basal-bolus approach)
    • Consider switching to a long-acting insulin analog (glargine, detemir) for basal coverage with less peak effect and more predictable action 2, 4

Monitoring and Follow-up

  • Check blood glucose 4 times daily (before meals and bedtime)
  • Add post-meal checks (2 hours after meals) to assess mealtime insulin adequacy
  • Adjust insulin doses every 3 days based on patterns 2
  • Target fasting glucose of 80-130 mg/dL and post-meal glucose <180 mg/dL

Common Pitfalls to Avoid

  1. Stacking insulin doses: Avoid giving multiple correction doses within 4 hours as this can lead to hypoglycemia due to overlapping insulin action 3

  2. Ignoring the cause: Investigate why hyperglycemia occurred (missed dose, excessive carbohydrates, illness, stress, or medication effect)

  3. Inadequate monitoring: Failure to check blood glucose frequently enough during dose adjustments can lead to continued hyperglycemia or hypoglycemia

  4. Not addressing meal coverage: NPH alone often provides inadequate coverage for meals, especially lunch and dinner 1

  5. Overlooking patient education: Ensure the patient understands insulin timing, administration technique, and hypoglycemia management

By implementing these interventions, you can effectively manage the current hyperglycemia while establishing a more appropriate insulin regimen to prevent future episodes of severe hyperglycemia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy for Hyperglycemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended initial dose of fast-acting subcutaneous insulin (e.g. aspart (NovoLog), glulisine (Apidra), or lispro (Humalog)) for an insulin-naive patient presenting to the Emergency Department (ED) with hyperglycemia?
What insulin dose adjustments are recommended for a 47-year-old type 2 diabetes patient on Lantus (insulin glargine) 55 units who will be NPO (nothing by mouth) at midnight and has undergone multiple tooth extractions?
What should the NPH insulin dose be for a patient with type 2 diabetes on Lantus (Insulin Glargine) 27 units, who received 6 units of fast-acting insulin and has a blood glucose level of 344?
What is the next step in management for a patient with severe hyperglycemia (blood glucose level 535 mg/dL) 30 minutes after administering 22 units of lispro insulin (rapid-acting insulin)?
Can I introduce mealtime insulin (e.g. Novolog (insulin aspart) or Humalog (insulin lispro)) to a patient with type 2 diabetes mellitus (DM2) on Levemir (insulin detemir) 22 units daily and Metformin (metformin hydrochloride) 1000mg twice daily (BID), who was previously well controlled with a sodium-glucose cotransporter 2 (SGLT2) inhibitor but can no longer afford it?
What is the best approach for managing a chronic obstructive pulmonary disease (COPD) exacerbation?
Can prostate cancer spread to other parts of the body?
How to manage hypernatremia in a patient with Chronic Kidney Disease (CKD) stage 4?
What is the next step for a patient with testicular cancer and chronic central line thrombosis on Eliquis (apixaban)?
What are normal Prostate-Specific Antigen (PSA) levels?
Can creatine supplementation decrease estimated Glomerular Filtration Rate (eGFR)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.